Consumers can expect to encounter smart toilets from various manufacturers, offering automated analysis of stool and urine for health tracking. These devices typically connect to companion apps, providing personalized data on gut health, hydration, and other metrics. However, widespread medical endorsement for these consumer-grade products is not yet established, and potential buyers should temper expectations regarding definitive diagnostic capabilities.
Image: courtesy of Wired
Smart Toilets: The Promise of Poop Analysis Collides With Medical Skepticism
Smart toilets equipped with AI, cameras, and sensors are now on the market, promising to analyze human waste for health insights. Companies like Kohler Health and Throne are selling these devices, but medical experts, particularly gastroenterologists, remain largely unconvinced about their actual benefits for the average consumer, raising questions about their utility beyond novelty.
Outlook
Background
The push to integrate artificial intelligence into daily health monitoring has reached an unexpected frontier: the bathroom. Smart toilets, as reported on September 3, 2026, by WIRED's Gabriela Galvin, are now using AI to scan and interpret human waste. These devices aim to provide users with insights into their gut health and overall well-being by tracking changes over time. Companies like Kohler Health, an offshoot of the plumbing giant, offer models like the Dekoda, priced at $449 plus an annual $130 family membership. Startup Throne, which secured $10 million in Series A funding in July 2026, sells its product for $399 with a $70 annual membership. Other players, including Vivoo with its Smart Toilet for urine analysis and Toto's Stool Scan in Japan, are also active in this emerging market. The technology typically involves embedded cameras and sensors that analyze the shape, color, and consistency of stool, as well as urine composition, feeding data into machine learning models. The goal is to establish a user's baseline and flag meaningful deviations, sending alerts and reports to a connected smartphone application. Despite the technological advancements and commercial availability, gastroenterologists have expressed skepticism, suggesting these devices offer little practical benefit for the average person's health monitoring. This contrasts with research efforts, such as those by Duke scientists, who are developing AI tools for standard toilets specifically to assist in managing chronic conditions like inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) by providing objective data to medical professionals.
Precedents
The emergence of smart toilets fits into a broader historical trend of consumer-grade health tracking. Over the past decade, wearable devices like smartwatches and fitness bands have become commonplace, monitoring everything from heart rate and sleep patterns to activity levels. These devices promise to empower individuals with personal health data, often encouraging proactive wellness management. However, the journey from consumer gadget to clinically validated medical device has been fraught with challenges. Many early wellness trackers faced criticism for lacking medical accuracy or providing data that was difficult for the average person to interpret or act upon meaningfully without professional guidance. The medical community has generally adopted a cautious stance, requiring rigorous clinical trials and regulatory approval before endorsing new health technologies for diagnostic or treatment purposes. This mirrors the current situation with smart toilets: while the technology is innovative, its direct medical utility for the general population remains unproven, echoing past debates about the efficacy and reliability of other personal health monitoring tools. The pattern suggests a familiar cycle: initial consumer excitement, followed by expert scrutiny, and eventually, either niche adoption, broad clinical validation, or a fade into novelty.
The introduction of AI-powered smart toilets represents more than just a new bathroom fixture; it marks a significant expansion of personal health tracking into highly intimate and previously unmonitored physiological functions. For consumers, it offers the alluring promise of early detection for potential health issues, particularly those related to gut health, an area of increasing public interest. However, the skepticism from medical professionals raises critical questions about the true value proposition. If these devices cannot provide medically actionable insights, consumers could be spending hundreds of dollars on technology that offers little more than anxiety-inducing data or, worse, false reassurance. The privacy implications are also substantial. Collecting and analyzing highly sensitive biological data from every toilet flush presents new challenges for data security and ethical use, especially if this information is shared with third parties or used for targeted advertising. For the healthcare industry, the tension between consumer wellness tech and clinical validation highlights an ongoing struggle: how to integrate innovative technologies safely and effectively into medical practice, ensuring they genuinely improve health outcomes rather than just generating data.
Scenarios
AnalysisOne clear outcome is the continued segmentation of the market for smart toilet technology. Consumer-focused devices, like those from Kohler and Throne, may continue to sell based on novelty and a general wellness appeal, particularly to early adopters interested in self-tracking. Their success will likely depend on marketing, design, and user experience, even if medical validation for the average user remains elusive. This suggests a future where these devices exist as high-end lifestyle products rather than essential health tools for the broader public.
Separately, the development of AI tools for specific clinical applications, as seen with Duke scientists' work for IBD and IBS patients, could lead to a more targeted and medically validated use of this technology. These systems would likely integrate into healthcare workflows, providing doctors with objective, consistent data to monitor chronic conditions. This path implies a future where smart toilet technology gains legitimacy within the medical community, but primarily for specific patient populations and under clinical supervision, rather than as a general wellness product.
A third possibility is increased regulatory scrutiny. As more companies enter this space and make health claims, government bodies and medical associations may step in to establish clearer guidelines for product efficacy, data accuracy, and privacy. This could force manufacturers to conduct more rigorous clinical trials, disclose limitations more explicitly, or even seek specific medical device approvals, potentially slowing market growth but enhancing consumer trust and product reliability.
Timeline
2026-07-01
Throne Secures Series A Funding
Throne, a startup developing AI-powered smart toilets, raised $10 million in a Series A funding round.
2026-08-30
Throne Product Shipments Begin
Reports emerged that Throne began shipping its smart toilet product to customers, coinciding with news of its recent funding round.
2026-09-03
WIRED Report on Smart Toilets
WIRED published an article by Gabriela Galvin detailing the emergence of AI-powered smart toilets for health analysis and highlighting expert skepticism.
Frequently Asked Questions
Smart toilets use cameras, sensors, and AI algorithms to analyze the physical characteristics of stool, such as shape, color, and consistency, and the chemical composition of urine. This data is then processed to provide insights into metrics like gut health, hydration levels, and potential irregularities.
Discussion
Be the first to share your thoughts.